Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Current Assets (2016 - 2025)

Historic Current Assets for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $2.0 billion.

  • Ptc Therapeutics' Current Assets rose 5666.99% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 5666.99%. This contributed to the annual value of $1.4 billion for FY2024, which is 1205.47% up from last year.
  • Latest data reveals that Ptc Therapeutics reported Current Assets of $2.0 billion as of Q3 2025, which was up 5666.99% from $2.3 billion recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Current Assets high stood at $2.3 billion for Q1 2025, and its period low was $517.3 million during Q3 2022.
  • Moreover, its 5-year median value for Current Assets was $1.1 billion (2021), whereas its average is $1.1 billion.
  • Per our database at Business Quant, Ptc Therapeutics' Current Assets crashed by 4884.37% in 2022 and then surged by 13716.51% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Current Assets (Quarter) stood at $954.4 million in 2021, then fell by 27.3% to $693.8 million in 2022, then soared by 75.65% to $1.2 billion in 2023, then rose by 12.05% to $1.4 billion in 2024, then skyrocketed by 47.03% to $2.0 billion in 2025.
  • Its Current Assets stands at $2.0 billion for Q3 2025, versus $2.3 billion for Q2 2025 and $2.3 billion for Q1 2025.